Pure Global AI
ANVISA registration 81733730008Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 81733730008TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDATRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECHRisk Class II
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
HEMOGLOBINA A1c CALIBRADORES
Risk class
Class II
Registration details
Registration Number
81733730008
Process Number
25351188011201971
CNPJ
15648426000204
Company information
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jun 03, 2019
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81733730008 and manufactured by TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH. The registration is held by TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.